Progressive multifocal leukoencephalopathy in patients with chronic liver disease successfully treated with pembrolizumab
- PMID: 38143261
- DOI: 10.1007/s00415-023-12163-6
Progressive multifocal leukoencephalopathy in patients with chronic liver disease successfully treated with pembrolizumab
References
-
- Schweitzer F, Laurent S, Cortese I et al (2023) Progressive multifocal leukoencephalopathy: pathogenesis, diagnostic tools, and potential biomarkers of response to therapy. Neurology 101:700–713. https://doi.org/10.1212/WNL.0000000000207622 - DOI - PubMed
-
- Cortese I, Muranski P, Enose-Akahata Y et al (2019) Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med 380:1597–1605. https://doi.org/10.1056/NEJMoa1815039 - DOI - PubMed
-
- Roos-Weil D, Weiss N, Guihot A et al (2021) Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard? J Neurol 268:2458–2465. https://doi.org/10.1007/s00415-021-10414-y - DOI - PubMed
-
- Boumaza X, Bonneau B, Roos‐Weil D, et al (2022) Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors. Ann Neurol 15: 10. Doi: https://doi.org/10.1002/ana.26512
-
- Barber DL, Wherry EJ, Masopust D et al (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682–687. https://doi.org/10.1038/nature04444 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
